Results 171 to 180 of about 67,462 (301)

Nonsurgical Management of Postinfarction Left Ventricular Free Wall Rupture With a Percutaneous Ventricular Assist Device. [PDF]

JACC Case Rep
Ando Y, Morishita T, Matsuda H.
europepmc   +1 more source

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya, Toru Kubo, Jin Endo, Seiji Takashio, Masatoshi Minamisawa, Jun Hamada, Tomonori Ishii, Hajime Abe, Hiroaki Konishi, Kenichi Tsujita   +9 more
wiley   +1 more source

Long-term left ventricular assist device support reinforces detrimental immunological effects. [PDF]

Front Immunol
Dieterlen MT, Sauskat M, Klaeske K, Messer EK, Jozwiak-Nozdrzykowska J, Dashkevich A, Borger MA, Eifert S, Nozdrzykowski M.   +8 more
europepmc   +1 more source

Prognostic role of high‐sensitivity cardiac troponin T in patients with cardiac sarcoidosis: insights from ILLUMINATE‐CS

ESC Heart Failure, Volume 12, Issue 2, Page 869-878, April 2025.
Abstract Aims The prognostic role of high‐sensitivity cardiac troponin T (hs‐cTnT) as a biomarker in patients with cardiac sarcoidosis (CS) has yet to be fully determined, especially when compared with B‐type natriuretic peptide (BNP). Methods and Results In this post‐hoc analysis of the ILLUMINATE‐CS (ILLUstration of the Management and prognosIs of ...
Yuichi Baba, Toru Kubo, Takeru Nabeta, Yuya Matsue, Takeshi Kitai, Yoshihisa Naruse, Tatsunori Taniguchi, Hidekazu Tanaka, Takahiro Okumura, Kenji Yoshioka, Hiroaki Kitaoka   +10 more
wiley   +1 more source

Evaluating the Prevalence of Optimal Neurodevelopmental Outcome at 4.5-Years in Children Previously on Ventricular Assist Device Support. [PDF]

Pediatr Transplant
Oliver S, Buchholz H, Freed DH, Jonker V, Joffe AR, Saeidian M, Dinu I, Urschel S, Pidborochynski T, Atallah J, Robertson CMT, Zvonkovic J, Conway J.   +12 more
europepmc   +1 more source

Ventricular assist device

, 2019
Maedeh Dorri, Craig Hacking, Henry Knipe
openaire   +1 more source

The role of cardiac acoustic biomarkers in monitoring patients with heart failure: A systematic literature review

ESC Heart Failure, Volume 12, Issue 2, Page 980-997, April 2025.
Abstract Heart failure (HF) creates a considerable clinical, humanistic and economic burden on patients and caregivers as well as on healthcare systems. To attenuate the significant burden of HF, there is a need for enhanced management of patients with HF.
Javed Butler, Malcolm Brown, Philippe Prokocimer, Ashley C. Humphries, Sophie Pope, Olivia Wright, Jun Su, Osama Elnawasany, Bogdan Muresan   +8 more
wiley   +1 more source

Prolonged ventricular fibrillation in a patient with left ventricular assist device

Türk Kardiyoloji Derneği Arşivi, 2018
Serkan Çay, Fırat Özcan, Özcan Özeke, Dursun Aras, Serkan Topaloğlu   +4 more
doaj   +1 more source

Successful allogeneic stem cell transplant in a patient with a left ventricular assist device: a novel case report. [PDF]

Ann Hematol
Zablonski KG, Sabir U, Mendler JH, Alexis JD, Webster M, Constine LS, Aljitawi O.   +6 more
europepmc   +1 more source

Outcomes and predictors of early infection after heart transplantation [PDF]

, 2018
Balsara, Keki, Itoh, Akinobu, Micek, Scott, Shultes, Kendall C, Shuster, Jerrica E, Tellor, Bethany R, Vader, Justin M   +6 more
core   +2 more sources